Grants and Awards
Thanks to Small Business Innovative Research (SBIR) grants under the auspices of the National Institutes of Health, our research programs include in-vivo detection, localization, and enhanced treatment of: (1) breast cancer; (2) ovarian cancer; (3) leukemia; (4) determination of transplanted organ rejection; and (5) neuropathological diseases, including Alzheimer's disease. These programs utilize our expertise in biomagnetic sensors and superparamagnetic nanoparticles targeted to specific cells through coatings of antibodies or other agents.
| Projects | Years | Source | Phase 1 | Phase 2 |
| In-Vivo Breast Cancer Imaging | 2002 - 2010 | NIH, NCI | ![]() |
![]() |
| Ovarian Cancer Imaging | 2004-2005 | DoD | ![]() |
|
| Biomagnetic Determination of Transplant Rejection | 2005 - 2011 | NIH, NIAID | ![]() |
![]() |
| Improving Biopsies Using Magnetic Nanoparticles | 2005 - 2011 | NIH, NCI | ![]() |
![]() |
| Detection of Alzheimer Disease | 2006 - 2007 | NIH, NIA | ![]() |
|
| Biomagnetic In-Vivo Imaging of Ovarian Cancer | 2008 - 2011 | NCI Fast-Track | ![]() |

